NCT07639450
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07639450
Title N-3C01 Monotherapy and Combination With PD-(L)1 Inhibitors in Advanced Solid Tumors (Solid Tumors)
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Hefei Xinzhu Biological Technology Co., Ltd.
Indications
Therapies
Age Groups: senior | adult
Covered Countries AUS

Facility Status City State Zip Country Details
GenesisCare Research NOT_YET_RECRUITING Saint Leonards New South Wales 2065 Australia Details
San Clinical Trials Unit NOT_YET_RECRUITING Wahroonga New South Wales 2076 Australia Details
Corner Edith & Platt Streets, , NSW 2298 Australia NOT_YET_RECRUITING Waratah New South Wales 2298 Australia Details
Hunan Cancer Hospital NOT_YET_RECRUITING Changsha Hunan 410013 China Details
Shanghai East Hospital RECRUITING Shanghai Shanghai Municipality 200000 China Details
Henan Cancer Hospital NOT_YET_RECRUITING Zhengzhou Zhengzhou 450000 China Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field